Skip to main content

Cryoport, Inc.

CYRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001124524

In the last 90 days, Cryoport, Inc. insiders filed 0 open-market purchases and 1 sale; 184 institutions reported holding it in 13F filings for Q2 2026, worth $707.5M in total; no superinvestor holds it.

Q3 2023 vs. Q2 2023

How the institutions holding Cryoport, Inc. changed between Q2 2023 and Q3 2023.

All holders in Q3 2023All holders in Q2 2023

13F holders of CYRX: Q2 2023 compared with Q3 2023
MeasureQ2 2023Of which not filed for Q3 2023Q3 2023Change
Holders1781159−18
Shares45.9M5.00K45.8M−73.9K (−0.2%)
Value$791.3M$86.3K$627.5M−$163.8M (−20.7%)

1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (13)

Institutions that held Cryoport, Inc. at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to CYRX in Q3 2023
InstitutionSharesValue% of portfolio
Balyasny Asset Management LLC584,965$8.02M0.02%
Assenagon Asset Management S.A.237,050$3.25M0.01%
Nordea Investment Management AB83,833$1.15M0.00%
Russell Investments Group, Ltd.33,846$464.0K0.00%
Campbell & CO Investment Adviser LLC24,891$341.3K0.04%
Bayesian Capital Management, LP20,000$274.2K0.03%
Pathstone Family Office, LLC12,049$165.2K0.00%
Winton Group Ltd11,854$162.5K0.01%
Ostrum Asset Management4,036$55.3K0.01%
Comerica Bank3,839$52.6K0.00%
Walleye Trading LLC471$6.46K0.00%
Valley National Advisers Inc40$1.00K0.00%
Glassman Wealth Services14$1920.00%

Sold out (31)

Institutions that held Cryoport, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.

Not filed for Q3 2023 yet (1)

Institutions that held Cryoport, Inc. at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CYRX in Q2 2023 that haven't filed for Q3 2023
InstitutionShares, Q2 2023Value, Q2 2023
BerganKDV Wealth Management, LLC5,000$86.3K